SCHEMBL812366

SCHEMBL812366

O=C1CCOCC1[Se]c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.41
ALOX5 P09917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL813145 0.73 MCL1 (0.40) MT-CO2ALOX5
SCHEMBL813136 0.71 MCL1 (0.46) MT-CO2ALOX5
SCHEMBL811778 0.70 MCL1 (0.45) MT-CO2ALOX5
SCHEMBL513596 0.69 MT-CO2 (0.44) MT-CO2ALOX5
SCHEMBL813131 0.67 DRD1 (0.35)
SCHEMBL29169545 0.66 MAOB (0.46) MT-CO2ALOX5
SCHEMBL28864275 0.66 DDB1 (0.45) MT-CO2ALOX5
SCHEMBL14169805 0.66 MAOB (0.46) MT-CO2ALOX5
SCHEMBL809471 0.66 DDB1 (0.45) MT-CO2ALOX5
SCHEMBL6755501 0.64 CTRB1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed
WO-2006007586-A1 ORGANOCATALYSTS AND METHODS OF USE IN CHEMICAL SYNTHESIS SCIENCE & TECHNOLOGY CORPORATION @ UNM (US) 2006-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis SCO2, CBR1, CBR3 MT-CO2 36/4885ALOX5 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.